T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-03
DOI
10.1038/srep27130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blinatumomab: First Global Approval
- (2015) Mark Sanford DRUGS
- Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer
- (2015) Julia Stieglmaier et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Engager T Cells: A New Class of Antigen-specific T Cells That Redirect Bystander T Cells
- (2015) Kota Iwahori et al. MOLECULAR THERAPY
- Survivin-specific T cell receptor targets tumor but not T cells
- (2014) Caroline Arber et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
- (2014) D J DeAngelo et al. LEUKEMIA
- Antibodies to watch in 2015
- (2014) Janice M Reichert mAbs
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
- (2013) D. T. Teachey et al. BLOOD
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting T cells to tumor cells using bispecific antibodies
- (2013) Stanley R Frankel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Design and development of therapies using chimeric antigen receptor-expressing T cells
- (2013) Gianpietro Dotti et al. IMMUNOLOGICAL REVIEWS
- Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
- (2013) Bipulendu Jena et al. PLoS One
- CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
- (2013) Marco L. Davila et al. PLoS One
- Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer
- (2012) Philippe Fournier et al. BIODRUGS
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab
- (2012) M. Klinger et al. BLOOD
- Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
- (2012) C.-H. Pui et al. BLOOD
- T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
- (2012) Kevin KH Chow et al. MOLECULAR THERAPY
- Children's Oncology Group's 2013 blueprint for research: Survivorship and outcomes
- (2012) Saro H. Armenian et al. PEDIATRIC BLOOD & CANCER
- T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies
- (2011) D. R. Shaffer et al. BLOOD
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells
- (2010) J. N. Kochenderfer et al. BLOOD
- Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
- (2010) R Handgretinger et al. LEUKEMIA
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Eradication of Established B-cell Lymphoma by CD19-specific Murine T Cells is Dependent on Host Lymphopenic Environment and Can be Mediated by CD4+ and CD8+ T Cells
- (2009) Eleanor J. Cheadle et al. JOURNAL OF IMMUNOTHERAPY
- A Novel Antibody–4-1BBL Fusion Protein for Targeted Costimulation in Cancer Immunotherapy
- (2008) Dafne Müller et al. JOURNAL OF IMMUNOTHERAPY
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search